Sickle Cell Disease Mortality in Brazil: Real-World Evidence

被引：2
|
作者：
Cancado, Rodolfo D. [1 ]
Costa, Fernando Ferreira [2 ]
Lobo, Clarisse [3 ]
Migliavaca, Celina Borges [4 ]
Falavigna, Maicon [4 ]
Souza Filho, Homero C. R. [5 ]
Bueno, Carolina Tosin [6 ]
Silva Pinto, Ana Cristina [7 ]
机构：
[1] Santa Casa Med Sch, Dept Hematol Oncol, Sao Paulo, Brazil
[2] Univ Estadual Campinas, Sch Med Sci, Campinas, SP, Brazil
[3] Inst Estadual Hematol Arthur Siqueira Cavalca, Rio De Janeiro, Brazil
[4] HT Analyze Consultoria & Treinamento, Porto Alegre, RS, Brazil
[5] Novartis Oncol, Dept Hematol Oncol, Sao Paulo, Brazil
[6] Novartis Oncol, Sao Paulo, Brazil
[7] Univ Sao Paulo, Ribeirao Preto Med Sch, Blood Ctr Ribeirao Preto, Ribeirao Preto, Brazil
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-151098
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3025
引用
收藏
页数：5
相关论文
共 50 条
  • [31] REAL-WORLD ANALYSIS OF THE HEALTHCARE RESOURCE CONSUMPTION AND RELATED COSTS OF SICKLE CELL DISEASE IN ITALY
    De Franceschi, L.
    Forni, G. L.
    Castiglioni, C.
    Condorelli, C.
    Valsecchi, D.
    Premoli, E.
    Perrone, V
    Degli Esposti, L.
    Fiocchi, C. A.
    VALUE IN HEALTH, 2022, 25 (01) : S64 - S64
  • [32] IS BRAZIL READY FOR THE REAL-WORLD
    MAPLESTON, P
    MODERN PLASTICS, 1995, 72 (07): : 35 - 35
  • [33] Real-World Experience of Patients with Sickle Cell Disease Treated with Crizanlizumab: A Single Comprehensive Sickle Cell Center Retrospective Cohort Analysis
    Chan, Kok Hoe
    Buddharaju, Ruhi
    Chang, Shandel L.
    Lane, John S.
    Idowu, Modupe
    BLOOD, 2022, 140 : 8288 - 8289
  • [34] Real-world evidence regarding the causal effect of pain on mortality
    Shen, Chun-Yu
    Li, Chen-Pi
    Gau, Shuo-Yan
    Chang, Hui-Chin
    Jhang, Yi-Sheng
    PAIN, 2025, 166 (03) : 710 - 710
  • [35] Mantle Cell Lymphoma in Brazil: First Report from a Real-World Evidence Study of a Third World Country
    Figorelle, Lara Gallucci
    Oliveira, Fernanda
    Lyrio, Renata
    Xavier, Flavia Dias
    Guarana, Mariana
    Sabioni, Bruna Souza
    Arrais-Rodrigues, Celso
    Lira, Noemi Da Silva
    Galvao, Peterson Tiago
    Milito, Cristiane
    Carneiro, Katia
    Vianna, Valeria
    Schaffel, Rony
    BLOOD, 2022, 140 : 13246 - 13247
  • [36] Use of Real-World Data and Real-World Evidence in Rare Disease Drug Development: A Statistical Perspective
    Chen, Jie
    Gruber, Susan
    Lee, Hana
    Chu, Haitao
    Lee, Shiowjen
    Tian, Haijun
    Wang, Yan
    He, Weili
    Jemielita, Thomas
    Song, Yang
    Tamura, Roy
    Tian, Lu
    Zhao, Yihua
    Chen, Yong
    van Der Laan, Mark
    Nie, Lei
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025, 117 (04) : 946 - 960
  • [37] Real World Evidence of Prescription Patterns and Effect of Oxbryta (voxelotor) for Patients with Sickle Cell Disease
    Shah, Nirmish
    Zaidi, Ahmar Urooj
    Callaghan, Michael U.
    Liles, Darla
    Johnson, Clarissa E.
    De Castro, Laura M.
    BLOOD, 2020, 136
  • [38] A Patient-Centric Approach to Improve the Understanding of Sickle Cell Disease Using Real-World Data
    Clay, E. Leila Jerome
    Bailey, Miranda
    Drozd, Dan
    Paulose, Jincy
    Ramscar, Nicholas
    Mace, Kieran
    Wormser, David
    BLOOD, 2020, 136
  • [39] Real-world effectiveness of voxelotor for treating sickle cell disease in the US: a large claims data analysis
    Shah, Nirmish
    Lipato, Thokozeni
    Alvarez, Ofelia
    Delea, Thomas
    Lonshteyn, Alexander
    Weycker, Derek
    Nguyen, Andy
    Beaubrun, Anne
    Agodoa, Irene
    EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (02) : 167 - 173
  • [40] Real-world implementation of the David-Carroll buprenorphine protocol for pain management in sickle cell disease
    Torres, Calia
    Galadanci, Najibah
    Osborn, Jeremy
    Kanter, Julie
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (09) : 1834 - 1836
12345